| scholarly article | Q13442814 |
| P50 | author | Andrew H Bell | Q56761693 |
| P2093 | author name string | B Milne | |
| R Quirion | |||
| A Hosokawa | |||
| K Jhamandas | |||
| K J Powell | |||
| M Sutak | |||
| P2860 | cites work | A calcitonin gene-related peptide receptor antagonist prevents the development of tolerance to spinal morphine analgesia | Q71001966 |
| Alteration of calcitonin gene related peptide and its receptor binding sites during the development of tolerance to mu and delta opioids | Q71626371 | ||
| Dextromethorphan attenuates and reverses analgesic tolerance to morphine | Q72137026 | ||
| Inhibition of cyclooxygenase-1 and -2 by R(-)- and S(+)-ibuprofen | Q73024814 | ||
| The nitric oxide/cyclic GMP system at the supraspinal site is involved in the development of acute morphine antinociceptive tolerance | Q74064514 | ||
| Glutamate, nitric oxide and cell-cell signalling in the nervous system | Q34579292 | ||
| Prostanoids synthesized by cyclo-oxygenase isoforms in rat spinal cord and their contribution to the development of neuronal hyperexcitability | Q35027006 | ||
| Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance | Q35085790 | ||
| Role of nitric oxide in the induction and expression of morphine tolerance and dependence in mice | Q35873401 | ||
| Functionally differentiating two neuronal nitric oxide synthase isoforms through antisense mapping: evidence for opposing NO actions on morphine analgesia and tolerance | Q36304967 | ||
| Blockade of tolerance to morphine but not to kappa opioids by a nitric oxide synthase inhibitor | Q36341020 | ||
| Opioid analgesics in cancer pain: current practice and controversies. | Q38189061 | ||
| Pharmacological differences between the optical isomers of ibuprofen: evidence for metabolic inversion of the (—)-isomer | Q39099127 | ||
| Mapping of prostaglandin E2 binding sites in rat brain using quantitative autoradiography | Q40733756 | ||
| Nitric oxide (NO) and nociceptive processing in the spinal cord | Q40887811 | ||
| Prostaglandin-induced neuropeptide release from spinal cord. | Q40940941 | ||
| Morphine dependence in human neuroblastoma SH-SY5Y cells is associated with adaptive changes in both the quantity and functional interaction of PGE1 receptors and stimulatory G proteins. | Q41236896 | ||
| Prostaglandin E2 enhances bradykinin-stimulated release of neuropeptides from rat sensory neurons in culture. | Q41662482 | ||
| Prostaglandin E2 increases calcium conductance and stimulates release of substance P in avian sensory neurons | Q42454277 | ||
| The treatment of cancer pain | Q43074092 | ||
| Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat | Q43453302 | ||
| The effects of substance P and calcitonin gene-related peptide on the efflux of endogenous glutamate and aspartate from the rat spinal dorsal horn in vitro | Q43555793 | ||
| Capsaicin-evoked prostaglandin E2 release in spinal cord slices: relative effect of cyclooxygenase inhibitors | Q44225100 | ||
| Functional coupling of the delta-, mu-, and kappa-opioid receptors to mitogen-activated protein kinase and arachidonate release in Chinese hamster ovary cells. | Q44342434 | ||
| Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C. | Q45085836 | ||
| Effect of spinal infusion of L-NAME, a nitric oxide synthase inhibitor, on spinal tolerance and dependence induced by chronic intrathecal morphine in the rat. | Q45094471 | ||
| Concurrent spinal infusion of MK801 blocks spinal tolerance and dependence induced by chronic intrathecal morphine in the rat. | Q46165376 | ||
| Spinal nitric oxide synthesis inhibition blocks NMDA-induced thermal hyperalgesia and produces antinociception in the formalin test in rats | Q46176636 | ||
| Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition | Q46223466 | ||
| Inhibition of opiate tolerance by non-competitive N-methyl-D-aspartate receptor antagonists | Q48191134 | ||
| How opioids inhibit GABA-mediated neurotransmission | Q48580369 | ||
| Determination of cross tolerance in rat spinal cord using intrathecal infusion via sequential mini-osmotic pumps. | Q50905900 | ||
| Ketamine attenuates and reverses morphine tolerance in rodents. | Q51556419 | ||
| Inhibition of Morphine Tolerance and Dependence by the NMDA Receptor Antagonist MK-801 | Q52052445 | ||
| Analgesia and autonomic function following intrathecal administration of morphine and norepinephrine to the rat. | Q54268335 | ||
| Inhibition of nitric oxide synthase attenuates the development of morphine tolerance and dependence in mice | Q56983569 | ||
| Cyclooxygenase-1 and Cyclooxygenase-2 Selectivity of Widely Used Nonsteroidal Anti-Inflammatory Drugs | Q57480336 | ||
| Intrathecal morphine inhibits substance P release from mammalian spinal cord in vivo | Q59061346 | ||
| NG-nitro-L-arginine prevents morphine tolerance | Q67575808 | ||
| Calcitonin gene-related peptide promotes mechanical nociception by potentiating release of substance P from the spinal dorsal horn in rats | Q68987789 | ||
| Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist, LY274614 | Q70602366 | ||
| Assembly of an inexpensive tail flick analgesia meter | Q70882313 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | opioid | Q427523 |
| P304 | page(s) | 631-644 | |
| P577 | publication date | 1999-06-01 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | Comparative effects of cyclo-oxygenase and nitric oxide synthase inhibition on the development and reversal of spinal opioid tolerance | |
| P478 | volume | 127 |
| Q44610342 | Attenuation of morphine tolerance, withdrawal-induced hyperalgesia, and associated spinal inflammatory immune responses by propentofylline in rats |
| Q36053125 | Augmentation of spinal morphine analgesia and inhibition of tolerance by low doses of mu- and delta-opioid receptor antagonists |
| Q42126244 | Blockade and reversal of spinal morphine tolerance by peptide and non-peptide calcitonin gene-related peptide receptor antagonists |
| Q24653404 | COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia |
| Q42326753 | Cannabinoid CB(2) receptor attenuates morphine-induced inflammatory responses in activated microglial cells |
| Q34126256 | Endogenous opiates: 1999. |
| Q43921525 | Ginseng total saponin potentiates acute U-50,488H-induced analgesia and inhibits tolerance to U-50,488H-induced analgesia in mice |
| Q36057741 | Improving opioid effectiveness: from ideas to evidence |
| Q35152165 | Induction of pain facilitation by sustained opioid exposure: relationship to opioid antinociceptive tolerance |
| Q41811767 | Intrathecal lamotrigine attenuates antinociceptive morphine tolerance and suppresses spinal glial cell activation in morphine-tolerant rats. |
| Q46920951 | Ketorolac prevents recurrent withdrawal induced hyperalgesia but does not inhibit tolerance to spinal morphine in the rat. |
| Q37268390 | Long-term Morphine-treated Rats are more Sensitive to Antinociceptive Effect of Diclofenac than the Morphine-naive rats |
| Q44462660 | Morphine and dipyrone co-administration delays tolerance development and potentiates antinociception |
| Q73072223 | Morphine treatment induced calcitonin gene-related peptide and substance P increases in cultured dorsal root ganglion neurons |
| Q43722386 | Opioids are non-competitive inhibitors of nitric oxide synthase in T47D human breast cancer cells |
| Q35044015 | Opioids: a review |
| Q30948599 | Periodic abstinence enhances nociception without significantly altering the antinociceptive efficacy of spinal morphine in the rat. |
| Q37328701 | Peroxynitrite and opiate antinociceptive tolerance: a painful reality |
| Q44586399 | Possible mechanisms of action in quercetin reversal of morphine tolerance and dependence |
| Q36838771 | Preventing the development of chronic pain after orthopaedic surgery with preventive multimodal analgesic techniques |
| Q44341481 | Prior ibuprofen exposure does not augment opioid drug potency or modify opioid requirements for pain inhibition in total hip surgery |
| Q34199035 | Prostaglandins and cyclooxygenases [correction of cycloxygenases] in the spinal cord |
| Q33640240 | Spinal NK-1 receptor expressing neurons mediate opioid-induced hyperalgesia and antinociceptive tolerance via activation of descending pathways |
| Q43263235 | Spinal administration of lipoxygenase inhibitors suppresses behavioural and neurochemical manifestations of naloxone-precipitated opioid withdrawal |
| Q43785293 | Spinal cord nitric oxide synthase and heme oxygenase limit morphine induced analgesia |
| Q34204447 | Sustained morphine treatment augments prostaglandin E2-evoked calcitonin gene-related peptide release from primary sensory neurons in a PKA-dependent manner |
| Q43542087 | The involvement of glial cells in the development of morphine tolerance |
| Q35164063 | The neurobiology of opiate tolerance, dependence and sensitization: mechanisms of NMDA receptor-dependent synaptic plasticity |
| Q24677387 | The role of spinal neuropeptides and prostaglandins in opioid physical dependence |
Search more.